Syngene International Limited (NSE:SYNGENE)
India flag India · Delayed Price · Currency is INR
703.25
-10.75 (-1.51%)
Aug 1, 2025, 3:29 PM IST

Syngene International Company Description

Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally.

The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and analytical chemistry; discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals; and chemical, formulation, analytical, and clinical development services.

It provides lead generation, preclinical development, API, and drug product development services; and clinical trial management, pharmacokinetic analysis/bioanalytical studies, biometrics and clinical data management, central lab, regulatory, medical monitoring, pharmacovigilance, and medical writing services.

In addition, the company offers chemistry, biology, safety assessment, computational, and data sciences for traditional small molecule therapeutics; biologics; and specialty modalities, such as peptides, oligonucleotides, antibody-drug conjugates, and targeted degradation/stabilization.

It serves pharmaceutical, biotechnology, animal health, nutrition, consumer goods, agrochemical, performance and specialty materials, and other companies.

The company has collaborations with Bristol-Myers Squibb, Baxter Inc., and Amgen Inc. The company was incorporated in 1993 and is headquartered in Bengaluru, India.

Syngene International Limited is a subsidiary of Biocon Limited.

Syngene International Limited
Syngene International logo
CountryIndia
Founded1993
IndustryDiagnostics & Research
SectorHealthcare
Employees6,533
CEOPeter James Bains

Contact Details

Address:
Biocon SEZ, Biocon Park
Bengaluru, Karnataka 560099
India
Phone91 80 6891 8000
Websitesyngeneintl.com

Stock Details

Ticker SymbolSYNGENE
ExchangeNational Stock Exchange of India
Fiscal YearApril - March
Reporting CurrencyINR
ISIN NumberINE398R01022
SIC Code8731

Key Executives

NamePosition
Peter James Jonathan BainsChief Executive Officer, MD and Director
Deepak JainChief Financial Officer
Dr. Jayashree Aiyar Ph.D.Chief Scientific Officer
Krishnan GHead of Investor Relations
Sandeep NairHead of Corporate Communications
Andrew WebsterChief Human Resources Officer
Dr. Dhananjay PatankarHead of Pharmaceutical and Biopharmaceutical Development
Purushottam Shashikant SingnurkarHead of Formulations Development
Ajit ManochaHead of IT
Dr. Chetan Prakash TamhankarHead of Clinical Development and Stability Studies